SHARE NOW
David Johnson, Sales and Marketing Director at 3P Innovation, gives an overview of the new GMP Cyrovial Filling Platform.
Part of the ‘Discover Range,’ the innovative device aims to automate the crucial process of filling cryovials with cell and gene therapy products, ensuring unprecedented levels of sterility and consistency. The CryoFil incorporates advanced technologies, including intelligent closed-loop filling, 100% weight verification, and a low-shear pump, minimizing cell damage and optimizing filling efficiency. The platform also facilitates automated cryovial placement into racks for swift transfer to controlled rate freezers, reducing contamination risks.
To read more about the CryoFil, check out this latest news story >>
The CryoFil offers benefits such as unprecedented sterility assurance, 100% in-process checks, maximized cell yield, precision and accuracy, compact versatility, and compliance with CFR 21 part 11 regulations. This innovation further solidifies 3P Innovation’s commitment to supporting early-stage drug development activities in the cell and gene therapy sector. The company plans to showcase the CryoFil at Advanced Therapies Week 2024, reinforcing its dedication to providing tools and technologies for advancing life-saving therapies.
Attending Advanced Therapies Week? Meet the 3P Innovation team at booth #701 to find out more >>
This tech demo has been produced in partnership with 3P Innovation.
